MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of their treatment offers them a better chance of being cured.
Kimberly Feigin, MD, has been named Chief of the Breast Imaging Service within the Department of Radiology. Dr. Feigin has ...
A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body forms immune cell ...
Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who ...
Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Neuro-oncologist Dr. Adrienne Boire discusses her path to becoming a cancer researcher, and on the parallel between science and another passion — knitting.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback